Eli Lilly and Company (NYSE: LLY), a United States-based pharmaceutical company, announced on Monday its dividend for the second quarter of 2023.
The company has declared a dividend of USD1.13 per share on outstanding common stock.
The dividend will be paid to shareholders of record at 15 May 2023 on 9 June 2023.
Egetis secures exclusive licence agreement with Fujimoto for Emcitate development in Japan
Perrigo announces quarterly dividend
Eli Lilly announces Q4 2023 dividend
Moderna and CEPI partner to accelerate mRNA vaccine development
OptiBiotix secures license agreement with Tata Chemicals for Indian market